Exact Sciences Corporation (EXAS) Soars 5.9%

Exact Sciences Corporation (EXAS) Soars 5.9%

Exact Sciences Corporation (EXAS) had a good day on the market for Thursday October 03 as shares jumped 5.9% to close at $92.62. About 2.83 million shares traded hands on 28,127 trades for the day, compared with an average daily volume of n/a shares out of a total float of 129.49 million. After opening the trading day at $87.28, shares of Exact Sciences Corporation stayed within a range of $92.97 to $86.88.

With today’s gains, Exact Sciences Corporation now has a market cap of $11.99 billion. Shares of Exact Sciences Corporation have been trading within a range of $123.99 and $53.06 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of certain types of cancer. Its core product is a noninvasive screening test, Cologuard, which analyzes stool-based DNA samples to detect the precancerous and early stages of colorectal cancer. The test includes DNA markers and a protein marker that can detect blood in the stool. Exact Sciences receives revenue from two sources: laboratory services and licensing fees. Its laboratory services revenue is generated by diagnostic services that use the Cologuard test. Exact Sciences also receives revenue from the licensing of its product rights.

Exact Sciences Corporation is based out of Madison, WI and has some 1,977 employees. Its CEO is Kevin T. Conroy.

Exact Sciences Corporation is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It’s maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell’s indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It’s a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

error: Content is protected !!